JP2007504268A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007504268A5 JP2007504268A5 JP2006526176A JP2006526176A JP2007504268A5 JP 2007504268 A5 JP2007504268 A5 JP 2007504268A5 JP 2006526176 A JP2006526176 A JP 2006526176A JP 2006526176 A JP2006526176 A JP 2006526176A JP 2007504268 A5 JP2007504268 A5 JP 2007504268A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition
- formulation
- igg
- prepared
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 claims 13
- 239000008194 pharmaceutical composition Substances 0.000 claims 13
- 238000009472 formulation Methods 0.000 claims 7
- 229940027941 immunoglobulin g Drugs 0.000 claims 6
- 239000002552 dosage form Substances 0.000 claims 2
- 239000000499 gel Substances 0.000 claims 2
- 239000002674 ointment Substances 0.000 claims 2
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims 1
- 238000010521 absorption reaction Methods 0.000 claims 1
- 239000003125 aqueous solvent Substances 0.000 claims 1
- 210000005178 buccal mucosa Anatomy 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000008309 hydrophilic cream Substances 0.000 claims 1
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 239000007937 lozenge Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 239000000829 suppository Substances 0.000 claims 1
- 230000002459 sustained effect Effects 0.000 claims 1
- 239000003826 tablet Substances 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 230000000699 topical effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/656,781 US6984492B2 (en) | 2003-09-05 | 2003-09-05 | Methods and compositions for treating herpes infections |
| PCT/US2004/028559 WO2005025617A2 (en) | 2003-09-05 | 2004-09-02 | Methods and compositions for treating herpes infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007504268A JP2007504268A (ja) | 2007-03-01 |
| JP2007504268A5 true JP2007504268A5 (https=) | 2007-10-18 |
Family
ID=34226428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006526176A Withdrawn JP2007504268A (ja) | 2003-09-05 | 2004-09-02 | ヘルペス感染症を処置するための方法および組成物 |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US6984492B2 (https=) |
| EP (1) | EP1663309A2 (https=) |
| JP (1) | JP2007504268A (https=) |
| KR (1) | KR20060107509A (https=) |
| CN (1) | CN1845756A (https=) |
| AU (1) | AU2004272001A1 (https=) |
| BR (1) | BRPI0414139A (https=) |
| CA (1) | CA2537360A1 (https=) |
| IL (1) | IL173805A0 (https=) |
| NO (1) | NO20061184L (https=) |
| NZ (1) | NZ546303A (https=) |
| WO (2) | WO2005023303A1 (https=) |
| ZA (1) | ZA200602738B (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2248825T3 (pl) * | 2009-05-04 | 2013-04-30 | Ribovax Biotechnologies Sa | Fragmenty przeciwciała wiążące antygen do zastosowania w leczeniu i diagnozowaniu chorób oczu |
| WO2013023362A1 (zh) * | 2011-08-16 | 2013-02-21 | 深圳市卫武光明生物制品有限公司 | 静注巨细胞病毒人免疫球蛋白及其制备方法 |
| US10829543B2 (en) | 2012-10-29 | 2020-11-10 | The University Of North Carolina At Chapel Hill | Compositions and methods for inhibiting pathogen infection |
| US10100102B2 (en) | 2012-10-29 | 2018-10-16 | The University Of North Carolina At Chapel Hill | Compositions and methods for inhibiting pathogen infection |
| WO2015134368A2 (en) * | 2014-03-03 | 2015-09-11 | Albert Einstein College Of Medicine Of Yeshiva University | Recombinant herpes simplex virus 2 (hsv-2) vaccine vectors |
| US10918712B2 (en) | 2014-03-03 | 2021-02-16 | Albert Einstein College Of Medicine | Passive transfer of immunity using recombinant herpes simplex virus 2 (HSV-2) vaccine vectors |
| CN114306596A (zh) * | 2014-06-26 | 2022-04-12 | 海德堡免疫疗法有限公司 | 抗hsv抗体的局部应用 |
| US9815886B2 (en) | 2014-10-28 | 2017-11-14 | Adma Biologics, Inc. | Compositions and methods for the treatment of immunodeficiency |
| WO2017083681A1 (en) | 2015-11-13 | 2017-05-18 | The University Or North Carolina At Chapel Hill | Optimized crosslinkers for trapping a target on a substrate |
| CN105532575A (zh) * | 2016-01-14 | 2016-05-04 | 中国科学院昆明动物研究所 | 一种单纯疱疹病毒感染树鼩动物模型的构建、评估方法及其应用 |
| US10259865B2 (en) | 2017-03-15 | 2019-04-16 | Adma Biologics, Inc. | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection |
| WO2020097528A1 (en) * | 2018-11-08 | 2020-05-14 | The Board Of Trustees Of The University Of Illinois | Treatment and diagnosis of autoantibody-mediated eye diseases |
| WO2021207348A1 (en) * | 2020-04-07 | 2021-10-14 | Albert Einstein College Of Medicine | Method of treating and preventing ocular disease with hsv-2 delta gd |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4617379A (en) * | 1983-06-14 | 1986-10-14 | Miles Laboratories, Inc. | High titer cytomegalovirus immune serum globulin |
| US4665159A (en) * | 1985-11-07 | 1987-05-12 | Miles Laboratories, Inc. | High titer varicella-zoster immune globulin for intravenous administration |
| US4717564A (en) * | 1985-11-07 | 1988-01-05 | Miles Laboratories, Inc. | High titer varicella-zoster immune globulin for intravenous administration |
| US5258177A (en) * | 1991-12-10 | 1993-11-02 | Alpha Therapeutic Corporation | IgA preparation and process of making the same |
| RU2051054C1 (ru) | 1992-04-14 | 1995-12-27 | Московский научно-исследовательский институт эпидемиологии и микробиологии им.Г.Н.Габричевского | Способ получения препарата противогерпетического иммуноглобулина человека |
| US5681565A (en) * | 1993-01-12 | 1997-10-28 | Medical Sciences Research Institute | Methods and compositions for passive immunotherapy |
| WO1994015640A1 (en) * | 1993-01-12 | 1994-07-21 | Anthony George Gristina | Methods and compositions for the direct concentrated delivery of passive immunity |
| AU6968098A (en) * | 1997-04-15 | 1998-11-11 | Advanced Viral Research Corp. | Topical treatment of skin diseases and eye afflictions |
| US5886154A (en) * | 1997-06-20 | 1999-03-23 | Lebing; Wytold R. | Chromatographic method for high yield purification and viral inactivation of antibodies |
-
2003
- 2003-09-05 US US10/656,781 patent/US6984492B2/en not_active Expired - Fee Related
-
2004
- 2004-08-24 WO PCT/EP2004/009434 patent/WO2005023303A1/en not_active Ceased
- 2004-09-01 BR BRPI0414139-3A patent/BRPI0414139A/pt not_active Application Discontinuation
- 2004-09-02 CN CNA2004800253052A patent/CN1845756A/zh active Pending
- 2004-09-02 WO PCT/US2004/028559 patent/WO2005025617A2/en not_active Ceased
- 2004-09-02 EP EP04782951A patent/EP1663309A2/en not_active Withdrawn
- 2004-09-02 NZ NZ546303A patent/NZ546303A/en not_active IP Right Cessation
- 2004-09-02 JP JP2006526176A patent/JP2007504268A/ja not_active Withdrawn
- 2004-09-02 AU AU2004272001A patent/AU2004272001A1/en not_active Abandoned
- 2004-09-02 KR KR1020067004565A patent/KR20060107509A/ko not_active Ceased
- 2004-09-02 CA CA002537360A patent/CA2537360A1/en not_active Abandoned
-
2006
- 2006-02-19 IL IL173805A patent/IL173805A0/en unknown
- 2006-03-03 US US11/367,772 patent/US20060198848A1/en not_active Abandoned
- 2006-03-14 NO NO20061184A patent/NO20061184L/no not_active Application Discontinuation
- 2006-04-03 ZA ZA200602738A patent/ZA200602738B/xx unknown
-
2009
- 2009-03-19 US US12/407,188 patent/US20090232798A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20190008795A1 (en) | Compositions for topical application of compounds | |
| US20090191288A1 (en) | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases | |
| CN111683653A (zh) | 用于局部递送的方法和组合物 | |
| JP2002522485A5 (https=) | ||
| US9662360B2 (en) | Treatment of herpes, pseudomonas, staph, and hepatitis | |
| JP2007515469A5 (https=) | ||
| CN105682639A (zh) | 口腔可分散膜 | |
| WO2004071529A3 (en) | Uses of anti-insulin-like growth factor i receptor antibodies | |
| JP2007504268A5 (https=) | ||
| CA2533591C (en) | Method for treatment of sores and lesions of the skin | |
| JP2026065074A (ja) | 新規多機能オリゴペプチド | |
| CN101278948B (zh) | 一种生物型药膜及其制备方法 | |
| AU777508B2 (en) | Methods and kits for treating vulvovaginal candidiasis with miconazole nitrate | |
| Rudy | Imiquimod (Aldara): modifying the immune response | |
| RU2237475C1 (ru) | Комбинированный препарат для устранения симптомов простудных заболеваний и гриппа (варианты) | |
| JP2009506002A (ja) | ライノウィルスの感染症治療の為のアンブロキソールの使用 | |
| TW202502805A (zh) | 新多功能寡肽 | |
| TW202038954A (zh) | 用於治療糜爛性手部骨關節炎的孟魯司特 | |
| JP2003055205A (ja) | 抗真菌病組成物 | |
| RU2008109165A (ru) | Применение скелета клеточной стенки nocardia rubra для получения лекарства против вируса папилломы человека (hpv) | |
| CN101284026B (zh) | 一种用于治疗皮肤过敏性疾病的药物组合物 | |
| WO2011064769A1 (en) | Methods and pharmaceutical compositions for the treatment of hot flashes | |
| CA2515259A1 (en) | Use of acetylsalicylic acid for the treatment of hemorrhoidal disease | |
| CN117338717B (zh) | 一种黄芩素外用制剂及其在特应性皮炎治疗中的应用 | |
| CN100558363C (zh) | 一种治疗尖锐湿疣的药物组合物 |